The single CpG methylation and HSPB2 expression differed regarding the G-CIMP status (or IDH mutations), but they were not significantly altered in GBMs or in IDH mutant gliomas compared to nontumor brains (Fig. 5a, b). Here, IDH1 is linked to central nervous system cancer.